Diclofenac ist eines der weltweit am häufigsten verwendeten Schmerzmittel – als Tablette, Gel, Pflaster oder Spritze. Es wirkt stark entzündungshemmend und schmerzlindernd, besonders bei Gelenk- und Muskelschmerzen, Arthrose und rheumatischen Beschwerden.

Diclofenac should be taken at the lowest effective dose for the shortest possible time. It is contraindicated in heart disease. This article does not replace medical advice.
Diclofenac is one of the most widely prescribed pain and anti-rheumatic medications in the world — and at the same time the NSAID with the highest cardiovascular risk among over-the-counter options. This is not a trivial matter: the combination of broad availability and substantial cardiac risk makes diclofenac one of the most pharmacologically important topics for public education in self-medication.
| Property | Details |
|---|---|
| Active substance | Diclofenac (as diclofenac sodium or potassium) |
| ATC code | M01AB05 |
| Drug class | Non-steroidal anti-inflammatory drug (NSAID) |
| Available forms | Tablets 25/50/75 mg, modified-release tablets 75/100 mg, gel 1–5%, patch, injection, suppositories, eye drops |
| Half-life | 1–2 hours (short!) |
| Onset of action | 30–60 min (oral), immediate (injection) |
| Bioavailability | approx. 50–60% |
| Maximum dose | 150 mg/day (oral) |
| Prescription status | Low doses over the counter (gel, low-dose); higher doses prescription only |
| Special feature | Highest cardiovascular risk of all OTC NSAIDs |
Diclofenac works — like all NSAIDs — by inhibiting the enzymes cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). These enzymes produce prostaglandins, which play a central role in inflammation, pain, and fever. Blocking the enzymes reduces prostaglandin production and thereby inflammation and pain. So far, so desired.
Here lies the pharmacological core of the problem. Diclofenac is more COX-2-selective than ibuprofen — it inhibits COX-2 more strongly relative to COX-1. This is actually a desirable property, because COX-2 is mainly responsible for inflammation. But COX-2 is also needed in the blood vessels: it produces prostacyclin there, a substance that dilates blood vessels and prevents platelets from clumping.
When diclofenac inhibits vascular COX-2, prostacyclin production falls. At the same time, thromboxane A2 — produced via COX-1 in the platelets — remains active. Thromboxane narrows blood vessels and promotes clot formation. The result is a shifted balance: more vasoconstriction, more thrombosis tendency — and therefore increased risk of heart attack and stroke. This same mechanism was also the problem with the coxibs (rofecoxib was withdrawn from the market in 2004 for exactly this reason). Pharmacologically, diclofenac is closer to the coxibs than to classical NSAIDs like ibuprofen.
Additionally, all NSAIDs inhibit prostaglandin production in the kidneys. Prostaglandins there are important for regulating kidney blood flow and blood pressure control. Their inhibition can raise blood pressure, worsen kidney function, and reduce the effect of blood pressure-lowering medications — which is particularly relevant for patients on ACE inhibitors or sartans.
Diclofenac is used for a broad spectrum of pain and inflammatory conditions. The most important principle: the lowest dose possible, for the shortest time necessary. This is not a hollow phrase — every additional day under diclofenac increases cardiac risk. Record your intake in your digital medication plan so all treating doctors are informed.
| Indication | Oral dose | Duration | Alternative |
|---|---|---|---|
| Acute pain (dental, headache) | 50 mg 2–3×/day | Max. 3–5 days | Ibuprofen, paracetamol (acetaminophen) |
| Osteoarthritis | 75–150 mg/day divided | Short-term only! | Topical gel preferred |
| Rheumatoid arthritis | 100–150 mg/day | Under medical supervision | Consider DMARDs instead of long-term NSAID |
| Back pain (acute) | 50–75 mg 2×/day | Max. 1–2 weeks | Gel + movement |
| Migraine | 50–100 mg (potassium salt) | Single dose during attack | Triptans |
| Joint pain (local) | Gel 3–4×/day | Up to 3 weeks | Ibuprofen gel |
The cardiovascular risk of diclofenac is clinically established and should not be underestimated. The most important study is the Coxib and traditional NSAID Trialists' Collaboration, a Lancet meta-analysis from 2013 that evaluated data from 639 randomised trials involving over 350,000 patients. The finding: diclofenac increases the risk of heart attack by approximately 40% — a figure comparable to that of the coxibs. As a reminder: rofecoxib (Vioxx) was withdrawn from the market in 2004 for the same risk. Danish real-world data from 2018 confirm: diclofenac has a higher cardiovascular risk than ibuprofen, naproxen, and paracetamol.
| NSAID | Heart attack risk (relative) | Stroke risk | GI bleeding |
|---|---|---|---|
| Diclofenac | ↑↑↑ (+40%) | ↑↑ | ↑↑ |
| Ibuprofen (>1,200 mg/day) | ↑↑ (+30%) | ↑ | ↑↑ |
| Naproxen | ↔ (neutral) | ↔ | ↑↑↑ (highest GI risk!) |
| Paracetamol (acetaminophen) | ↔ (neutral) | ↔ | ↔ |
| Celecoxib (coxib) | ↑ | ↑ | ↓ (lower than traditional NSAIDs) |
Important context: the 40% relative risk refers to chronic use. For a healthy 35-year-old who takes diclofenac once for three days for toothache, the absolute risk is extremely low. For a 68-year-old patient with high blood pressure who takes diclofenac for weeks for arthritis pain, it is clinically relevant. The risk is therefore strongly context-dependent — and must always be assessed individually.
This is one of the most clinically important and at the same time least known interactions in pain medicine. Low-dose aspirin works by irreversibly binding to the COX-1 site in the platelets and permanently blocking it. Diclofenac (and ibuprofen) block the same binding site — but reversibly. If diclofenac is taken before aspirin, it occupies the binding site before aspirin can dock. Aspirin finds no free site and cannot exert its irreversible inhibition. Result: the heart-protective effect of low-dose aspirin is cancelled. Anyone taking daily aspirin for heart protection should therefore switch to paracetamol as their painkiller.
The Triple Whammy is one of the most dangerous combinations in general medicine — and at the same time one of the most common. The principle is the same as described in the candesartan article: NSAID + ACE inhibitor or sartan + diuretic strikes kidney function from three directions simultaneously.
NSAIDs like diclofenac reduce prostaglandin production in the kidneys, decreasing renal blood flow. ACE inhibitors like ramipril and sartans like candesartan dilate the efferent kidney vessels and thereby lower filtration pressure. Diuretics such as hydrochlorothiazide (HCTZ) or furosemide reduce circulating blood volume. Together, these three effects can cause acute kidney failure — particularly with dehydration, heat, or in older patients.
How does this combination arise in everyday life? A typical patient takes ramipril plus a diuretic for high blood pressure. They get back pain and buy diclofenac over the counter at the pharmacy — not knowing they are placing a triple burden on their kidneys. At the same time, diclofenac weakens the effect of ramipril and candesartan: blood pressure rises, and the patient wonders why their blood pressure tablets "no longer work". brite's interaction check detects this combination automatically.
Like all NSAIDs, diclofenac inhibits prostaglandin production in the stomach lining. Prostaglandins there are responsible for the mucus production that protects the stomach wall from aggressive hydrochloric acid. Without this protection, the risk of gastric ulcers and gastrointestinal bleeding rises — even with short-term use. Black stools are a warning sign of a gastrointestinal bleed and always constitute a medical emergency.
The gastrointestinal risk with diclofenac is lower than with naproxen, but higher than with paracetamol. It can however be substantially reduced by concurrent stomach protection.
| Risk factor | Increased risk |
|---|---|
| Age > 65 years | 2–4-fold |
| Concurrent corticosteroids (prednisolone) | 4–5-fold |
| Concurrent SSRI (citalopram) | 12-fold! |
| Concurrent low-dose aspirin | 2–3-fold |
| History of peptic ulcer | 10-fold |
| Anticoagulants (warfarin) | 6–10-fold |
Diclofenac gel (known as Voltaren Emulgel) is a genuine alternative to the tablet for localised complaints — and in many cases the safer choice. The decisive difference lies in systemic drug levels: while an oral tablet delivers the active substance into the entire bloodstream, less than 5% of the applied substance from the gel formulation reaches the systemic circulation. The cardiac, gastric, and renal risk is practically not elevated with topical use — provided the gel is applied only to the skin and not over large body surface areas.
| Diclofenac oral (tablet) | Diclofenac topical (gel) | |
|---|---|---|
| Systemic drug levels | High | Minimal (<5% of oral dose) |
| Cardiac risk | Elevated | Not elevated (with local use) |
| Gastrointestinal risk | Elevated | Not elevated |
| Renal risk | Elevated | Not elevated |
| Blood pressure interaction | Yes | No |
| Efficacy for osteoarthritis (knee, hand) | Good | Good — comparable to tablet! |
| Efficacy for deep joints (hip) | Good | Limited (too deep for penetration) |
| Over the counter | Partially | Yes |
Diclofenac has a broad interaction profile that goes beyond simple painkiller thinking. Interactions with cardiovascular medications, which are frequently combined in everyday life, are particularly relevant. Check all your combinations with the interaction check.
| Substance / medication | Interaction | Recommendation |
|---|---|---|
| Ramipril / candesartan | Blood pressure lowering reduced + renal risk | Avoid combination. If necessary: short-term + monitor kidney values |
| Diuretics + antihypertensives | Triple Whammy → acute kidney failure | CONTRAINDICATED as a three-way combination! |
| Low-dose aspirin (blood thinning) | Diclofenac blocks COX-1 → aspirin heart protection cancelled! | Paracetamol instead of NSAID for aspirin patients! |
| Corticosteroids (prednisolone) | Gastrointestinal bleeding risk massively increased | Avoid. If necessary: add pantoprazole |
| SSRIs (citalopram, sertraline) | 12-fold increased GI bleeding risk | Paracetamol instead of NSAIDs! |
| Methotrexate | Levels elevated → toxicity | Only under medical supervision |
| Lithium | Levels elevated → toxicity | Monitor lithium levels |
| Warfarin / rivaroxaban (Xarelto) / apixaban (Eliquis) | Increased bleeding risk | Monitor INR; avoid combination |
| Alcohol | Increased gastrointestinal bleeding risk | Avoid alcohol while taking NSAIDs |
Choosing the right painkiller is not a matter of preference — it depends on the patient's individual risk profile. A healthy adult without underlying conditions has a wide choice. Anyone with heart problems, stomach problems, or impaired kidney function must choose very carefully — and almost always ends up with paracetamol.
| Property | Diclofenac | Ibuprofen | Naproxen | Paracetamol |
|---|---|---|---|---|
| Anti-inflammatory | Yes — strong | Yes — moderate | Yes — strong | No |
| Cardiac risk | ↑↑↑ (highest!) | ↑↑ (at high doses) | ↔ (neutral) | ↔ (neutral) |
| Gastrointestinal risk | ↑↑ | ↑↑ | ↑↑↑ (highest!) | ↔ (low) |
| Renal risk | ↑↑ | ↑↑ | ↑↑ | ↑ (only at high doses) |
| Cancels aspirin heart protection | Yes! | Yes! | Less so | No |
| Gel available | Yes | Yes | No | No |
| OTC price | £2–5 | £1–3 | £3–6 | £1–2 |
Cardiac patient: Paracetamol (acetaminophen) is the first choice. If anti-inflammatory action is needed, naproxen can be considered short-term — it has the most favourable cardiovascular profile among NSAIDs. No diclofenac, no high-dose ibuprofen. Patient with stomach problems: Paracetamol or celecoxib plus pantoprazole. Patient with kidney impairment: Paracetamol only — all NSAIDs burden the kidneys. Patient on blood pressure medication (ramipril or candesartan): Paracetamol; no long-term NSAID.
In older patients over 65, the risk of all NSAID side effects is increased — cardiac risk, gastrointestinal bleeding, and kidney failure occur more frequently. Guidance here: prefer gel, if oral use is unavoidable then use the lowest dose for the shortest time and always add pantoprazole. In children, diclofenac is only licensed from age 14; for younger patients, ibuprofen or paracetamol are the appropriate medicines.
The brite app paints a clear picture: cardiac risk and the Triple Whammy are by far the most common knowledge gaps among diclofenac users. Many patients reflexively reach for diclofenac without knowing what other medications they are taking — and which combinations are dangerous.
| Observation | Frequency | Typical comment |
|---|---|---|
| Diclofenac + ramipril + HCTZ (Triple Whammy) | Very common | "The app warned me — nobody had mentioned it before." |
| Diclofenac despite heart disease | Common | "I had no idea diclofenac is prohibited with heart problems." |
| Gel instead of tablet not known | Common | "I didn't know gel works just as well for the knee." |
| Blood pressure rises on diclofenac | Common | "My blood pressure tablets suddenly seemed to stop working." |
| No stomach protection in older patients | Occasional | "No one ever suggested pantoprazole alongside it." |
| Aspirin heart protection cancelled | Occasional | "I take both aspirin 75 mg AND diclofenac — the app explained that this blocks the protection." |
Particularly striking: many patients don't know that diclofenac reduces the effectiveness of their blood pressure tablets. They then increase the dose of their antihypertensives — not realising that the actual problem is the painkiller. Anyone being treated with antihypertensives should always have their complete medication list to hand — including at the pharmacy.
How long can I take diclofenac? The basic rule: as short as possible. Without medical supervision, a maximum of 3–5 days for acute pain. For back or joint pain, a maximum of 1–2 weeks. If longer use is needed — for example with osteoarthritis or rheumatoid arthritis — medical oversight, regular blood pressure monitoring, and kidney value checks are mandatory. The thought "I've been taking it for weeks and feel fine" is deceptive — cardiovascular risk accumulates over time.
Diclofenac gel duration of action — how often to apply? Diclofenac gel is applied 3–4 times daily to the painful area. The effect lasts approximately 4–6 hours. Important: allow the gel to dry for a few minutes after application before putting clothing on. Do not apply to open wounds or inflamed skin. Do not use simultaneously with heat (heat pads, sauna) — this increases absorption and can cause local irritation.
Diclofenac in the morning or evening? There is no pharmacological preference for a particular time of day. What matters is consistency and taking it after a meal to minimise stomach burden. Modified-release tablets taken once daily can be taken in the morning or evening. Anyone who experiences pain during afternoon physical activity can time the dose accordingly.
Diclofenac and exercise — is it okay? Generally yes, but with one important caveat: NSAIDs can suppress the body's own inflammatory response that is necessary for healing muscles and tendons. Anyone taking diclofenac after exercise to dampen pain and then continuing to train risks overlooking or worsening a genuine injury. Joint pain during exercise should always be taken seriously.
Diclofenac heart attack risk — how high is it really? The 40% relative risk from the Lancet meta-analysis sounds alarming — but must be put in context. For a healthy 30-year-old with an absolute heart attack risk of 0.1%, a 40% increase means an absolute risk of 0.14% — barely perceptible. For a 65-year-old smoker with hypertension and an absolute risk of 5%, the same increase means a risk of 7% — that is clinically relevant. Diclofenac's cardiac risk is therefore context-dependent and should be individually assessed with a doctor.